Efficacy and safety of anaplastic lymphoma kinase inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis

Nav

General Info

Geography

Global

Coverage type

Global

Time period covered

01/2013 - 12/2021

Data type

Scientific literature

Keywords

Trachea, bronchus, and lung cancers

Citation

Authors

Peng TR, Liao PF, Wu TW

Journal

Thorac Cancer

Volume

Issue

Pages

929-939

Publication year

2023

Suggested citation

Peng TR, Liao PF, Wu TW. Efficacy and safety of anaplastic lymphoma kinase inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis. Thorac Cancer. 2023; 14(10): 929-939.

DOI

1011111759771414824

PMID

36908264

GHDx Entry last modified on: Mar 25, 2025

Header sites

Search form

Main menu

Efficacy and safety of anaplastic lymphoma kinase inhibitors for non-small cell lung cancer: A systematic review and network meta-analysis

Nav